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for effective infection control programmes and guiding effective treatment approaches. There are currently no epidemiological data on nation-wide burden of fungal infections in Turkey, a country located at the crossroads between Eastern Europe and Western Asia with prominent geographical and socioeconomic diversity. Several studies have examined the epidemiology of fungal infections and antifungal utilisation in Turkey, [7] [8] [9] [10] but most were local, single-centre or regional and focused on individual infections in specific populations. For instance, the epidemiology of candidiasis was evaluated retrospectively at the Hacettepe University
Hospital in Ankara between January 2001 and December 2010.
Among 381 candidaemia episodes, 58.3% were due to C. albicans, followed by C. parapsilosis (15.2%), C. tropicalis (13.4%) and C. glabrata (6.8%). 9 A single-centre study between October 2012 and December 2013 at Ege University in Iżmir showed that incidence of proven and probable invasive fungal infections (IFIs) was 6.7%
in those with haematological disease. Prophylaxis and antifungal therapy were given only in 30.5% and 23.6% of 522 chemotherapy episodes, respectively. 8 Another study reported the epidemiological trends in antifungal treatment on the national level; 11 408 patients and 505 episodes of invasive fungal infections was recorded. In this study, data were collected from 7 major hospitals (7052 beds), representing 26% of all the beds in university hospitals and 16% of all education hospitals across Turkey. However, these data are over 15 years old. In another retrospective study, 12 the cumulative incidences of invasive fungal infections in Turkish paediatric allogeneic hematopoietic stem cell transplant (HSCT) recipients receiving fluconazole prophylaxis were 2.7%, 5.0% and 6.5% at 30, 100 and 180 days post-transplantation, respectively.
Among 408 patients, 77 (18.9%) died within 180 days after HSCT, and fungal infections accounted for 1.5% of these cases (6/408) (IFI-related mortality). The overall mortality (case fatality) rate for all types of IFI was 27% (7/26) at 180 days. 12 Given that Turkey's unique geographical situation has been responsible for the epidemiology of various infectious diseases occurring throughout the country, [13] [14] [15] here we sought to provide an estimate of the national burden of serious fungal infections in Turkey, using a modelling approach previously applied to over 50 countries.
| MATERIAL S AND ME THODS
A systematic literature review for incidence and prevalence of fungal diseases was conducted in both local and international research databases including PubMed website and Google Scholar to identify fungal infections frequencies and specific populations at risk in Turkey from 1920 to 2017. We used the search terms "Turkey", "fungal infections", "cryptococcosis", "pneumocystis", "Aspergillus", "invasive aspergillosis", "chronic pulmonary aspergillosis", "allergic bronchopulmonary aspergillosis", "fungal rhinosinusitis", "Candida", "candidemia", "candidiasis", "recurrent Candida vaginitis", "mucormycosis", "fusariosis", "sporotrichosis", "histoplasmosis", "mycotic keratitis", "tinea", "onychomycosis", "Malassezia", "melanized fungi" and "Scedosporium." The search was supplemented by consultation of the bibliographies of the articles retrieved. No language restrictions were applied to the search. The burden of serious fungal diseases was then estimated, using literature review and methodology previously described by the LIFE program. 6, 16, 17 Where there were no data, we used proportion of specific risk groups and fungal infection frequencies in each population to estimate national incidence or prevalence, depending on the condition. The first case of Pneumocystis pneumonia (PCP) in Turkey was reported in 1955. 18 Since then, the majority of studies in Turkey have been directed towards evaluation of efficacy of diagnostic methods. 19 The prevalence of PCP in AIDS patients was assessed assuming that 5.5% of new AIDS cases present this infection, according to the report of Serraino et al 20 from Eastern Europe.
The first isolation of Cryptococcus from Turkey was reported in 1959 from a patient with intestinal infection. 21 In the current study, the rates of cryptococcal meningitis were estimated at 0.6 per 100 000 based on the published data in HIV patients. 6 To date, no adult asthma epidemiology studies have been recorded for Turkey. Due to lack of local data, the estimate of asthma prevalence in adults in Turkey was obtained from the 2003 World Health Survey published by To et al. 22 The burden of ABPA in adults with asthma and its correlation with CPA was considered 2.5%
(range 0.72%-3.5%). 23 The prevalence of severe asthma with fungal sensitisation (SAFS) was estimated as the worst 10% of the total asthma population, of whom at least 33% have fungal sensitisation.
The number of patients with COPD in the general population of The rate of IA in the context of hospitalised patients with COPD was estimated 13 cases per 1000 admissions as described previously by Guinea et al. 29 Recent data also suggest that chronic rhinosinusitis affects approximately 1%-1.5%, 11% and 12.5% of the population in North India (rural), the European Union and the United States, respectively. 30 , 31 The proportion of allergic rhinosinusitis attributed to fungal sensitisation appears to vary between 0.11% and 27%, [31] [32] [33] [34] [35] depending on the geographical regions favouring hot and humid climates and diagnostic methods used. To estimate the prevalence of allergic fungal rhinosinusitis (AFRS), we assumed that a conservative proportion of 5% of chronic rhinosinusitis in Turkey are AFRS. HSCT and solid organ transplantation (SOT), the incidence of IA and mucormycosis was evaluated according to previous LIFE database recommendations. 6 To estimate the number of candidaemia and Candida peritonitis cases, the annual incidence of 5/100 000 and 1.5/100 000, respectively, was used, in the absence of any national or regional population incidence data. 39, 40 In Turkey, the number of patients on renal replacement therapy in 2008 was 756 per million, and 10% were receiving chronic ambulatory peritoneal dialysis (CAPD) (n = 6109). 41 We assumed an infection rate of 1.6 episodes/patient-year and that 2% were attributable to fungi. 42 The burden of oropharyngeal and oesophageal candidiasis was assessed using incidence data previously published in the literature. [43] [44] [45] The number of women probably suffering from recurrent vulvovaginal candidiasis (RVVC) was estimated by assuming that RVVC affects 6% of adult women aged between 15 and 50 years. 46, 47 The prevalence of presenting corneal diseases and infectious keratitis was considered 0.8% and 0.148% of general population as previously reported. 48 The incidence of fungal keratitis was then estimated by using data obtained from documented studies in Turkey. 49 The estimates for cases of onychomycosis (2.8%) and tinea pedis (2.9%) in the general adult population of Turkey were derived from the study published previously. 50 The number of patients with tinea capitis was considered 0.23% among children population. 51 The incidence of uncommon and emerging fungal diseases such as mucormycosis, Scedosporium infections, sporotrichosis and disseminated infections by melanised fungi was estimated from the number of reported cases per year nationally.
| RE SULTS AND D ISCUSS I ON
In 2017, the population of Turkey was estimated at 80 810 525 inhabitants, of which 86.4% were adults and 23.6% were children 0-14 age group. The female population (40 243 641 persons) constituted 49.8%. The elderly population (65 years and over) was 8.5%.
The gross domestic product of Turkey per person in 2016 was USD 10 788. Turkey population density map is shown in Figure 1 .
The documented episodes of opportunistic fungal infections from 1920 to 2017 (Table 1) were as follows: 66 cases of Table   S1 .
Using local data and available national and international literature estimates of the incidence or prevalence of fungal infections, approximately 1 785 811 (2.21%) people in Turkey are estimated to suffer from a fungal infection in Turkey each year. Table 2 summarises the burden of different fungal diseases and their incidence or prevalence per 100 000 inhabitants as estimated from our study.
| Cryptococcal meningitis and PCP
Cryptococcal meningitis and PCP are among the most severe opportunistic infections occurring in HIV/AIDS populations.
According to the UNAIDS 2012 report, people living with HIV/ AIDS in Turkey ranged between 4000 and 7000 with approximately 56% (45%-72%) of patients receiving antiretroviral therapy (ARV). In the current study, 66 cases of cryptococcal meningitis, and 101 cases of PCP, 52 were diagnosed over an 18-year period (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) . Taking undiagnosed HIV/AIDS infections into account and based on the incidence rate published previously, 6, 20 one might expect that yearly as many as 106 and 635 cases of cryptococcal meningitis and PCP, respectively, occur in HIV/AIDS patients across Turkey, each year. 
| Invasive aspergillosis (IA)
In our study, a total of 3911 cases (4.84/100 000 annually) of IA were estimated to occur in Turkey, mainly in cancer/immunocompromised patients followed by patients with severe COPD and those hospitalised in ICU.
IA is a common complication in severely immunocompromised patients with haematological malignancies, such as bone marrow transplantation recipients or patients under extensive chemotherapy for haematological malignancies. According to the GLOBOCAN database, the prevalence of AML was considered 2.8/100 000 indicating that 453 cases are susceptible to IA annually, assuming that 10% of AML and some other haematological patients develop IA. 36, 37 Patients with solid tumours also are at risk for IA because they may develop neutropenia as a result of chemotherapy and radiotherapy. 38 The estimated number of IA in the lung cancer population of we estimate that TB contributes 33% of the cases and the overall prevalence of CPA is 5890 (7.3/100 000).
ABPA and SAFS are the most common fungal infections among asthmatics with a notably high prevalence rate. 
| Allergic fungal rhinosinusitis (AFRS)
AFRS is a unique variety of chronic polypoid rhinosinusitis mainly in atopic individuals, characterised by presence of eosinophilic mucin and fungal hyphae in paranasal sinuses without invasion into surrounding mucosa. 59 The fungi causing AFRS have a great diversity and regional variation, and the incidence of AFRS has been reported worldwide. 30 Histopathologic analysis of Turkish patients who underwent endoscopic sphenoidotomy revealed that fungal infection is a common cause of (14.1%) sphenoid sinus lesions. 60 Based on geoclimatic characteristics of Turkey, [13] [14] [15] high incidence rates of AFRS are predicted. However, published data are limited to microbiological analysis and single-centre case series. [61] [62] [63] Assuming a 5% population prevalence for allergic rhinosinusitis, we estimated that AFRS affects 312 994 adults (392/100 000) in Turkey annually (Table 2) . 
TA B L E 2 The estimated burden of serious fungal infections in Turkey
| Mucosal candidiasis
Vulvovaginal candidiasis (VVC) is the second most common cause of vaginitis after bacterial vaginosis, and it is diagnosed in up to 40%
of women with vaginal complaints in the primary care setting. 67 The presence of Candida in the vagina in the absence of immunosuppression or damaged mucosa is usually not associated with any signs of disease, which is referred as "asymptomatic colonisation."
VVC, however, is defined as signs and symptoms of inflammation in the presence of Candida spp. and in the absence of other infectious aetiologies. 46 Among problematic superficial mycoses, RVVC should be considered the most common fungal infection in Turkey.
RVVC is defined as at least four episodes per year (>4 times/y). 46, 47 The Turkish prevalence of RVVC per year was calculated by applying 6% to the adult women's population (between 15 and 50 years old) (n = 22 506 176), yielding an estimated 1 350 371 cases present.
Of note, RVVC is very common among women worldwide and reported to affect 5% to 9% of women of reproductive age. 46, 47 The gold standard mycological methods used for diagnosis include microscopic examination, fungal culture and antigen tests. Candida spp. were isolated from 44.2% of contraceptive method users and 37.9% of noncontraceptive users (P > 0.05). The isolation rate of C. albicans was higher among oral-contraceptive users (57.5%) than IUCD users (38.5%), coitus interruptus (48.5%) and condom users (42.8%). 67 In another study, the use of antibiotics, intrauterine devices (IUDs), perineal laceration, short anovaginal distance (<3 cm) and genital epilation were predisposing factors for RVVC.
Moreover, few studies are available on superficial fungal infections of the male genitalia in Turkey. 68 Iskit et al 69 In HIV patients, oral candidiasis is a frequent condition occurring at least once in 90% in those with low CD4 cell counts. 43, 44 Using this assumption, HIV infection is responsible for 4050 cases, and other risk groups, such as head and neck cancer and inhaled corticosteroids contribute more cases. So at least 4536 cases of oral candidiasis are annually expected, but these numbers will be an underestimate, as oropharyngeal candidiasis occurs in multiple other patients, such as immunocompromised patients after chemotherapy.
Oesophageal candidiasis is another AIDS-defining illness affecting nearly 20% of patients without ARV and 5% of patients on ARV. 45 Thus, at least 618 cases of oesophageal candidiasis (0.76/100 000) are expected to occur annually in Turkey. Usually, two or more episodes of oral candidiasis occur each year in these subjects.
| Mucormycosis
Mucormycosis is a life-threatening infection responsible for increasing morbidity and mortality in patients who are immunocompromised because of diabetic ketoacidosis, neutropenia, organ transplantation and/or increased serum levels of available iron. Based on the observations made from literature reviewed in this study (Table 1) , most of the infections occurred in patients with haematological malignancy (223 cases) and diabetic ketoacidosis (214 cases).
| Uncommon and emerging fungal diseases
In the context of the increasing patient population with immunosuppression and the expanding use of antifungal agents against common fungal pathogens such as Candida and Aspergillus, the number of patients with invasive fungal diseases due to emerging and uncommon fungal pathogens is increasing, worldwide. 71 However, according to our estimates, invasive scedosporiosis, fusariosis, sporotrichosis and disseminated infections by melanised fungi are rare fungal infections in Turkey (Table 1 ). In addition, there are a limited number of histoplasmosis cases reported from Turkey, 72, 73 given that infected patients are mostly asymptomatic. Of note, the first case of histoplasmosis was reported in Turkey in 1946 by Saglam. 74 Moreover, a recent study in Turkey found that 14.2% of the iatrogenically immunosuppressed patients without HIV had pulmonary microsporidiosis, 75 
| Fungal keratitis
Fungal keratitis is a challenging condition in ophthalmological practice in developing countries, including Turkey. 77 bial keratitis are due to fungi, we estimated the incidence of fungal keratitis in Turkey at 33 per 100 000 population annually, which suggests fungal keratitis is a particular problem in Turkey. This estimate is more than expected number of cases in Italy (0.94/100 000), 16 Malaysia (1.3/100 000) 78 and Egypt (14/100 000) 79 and less than Pakistan (44/100 000) 80 and Nepal (73/100 000). 
| Superficial mycoses
It is generally considered that dermatophytic infections are the most common types of human fungal infections, worldwide. Using local data and available national and international literature, there were many documented cases of superficial mycoses including dermatophytic infections in Turkey ( Table 1 ). The estimated annual incidence of superficial fungal infections in Turkey is shown in Table 3 .
Historically, the chronic hyperkeratotic (moccasin) tinea pedis also known as "two feet-one hand syndrome" was reported for the first time in 1892 by an Ottoman dermatologist "Celal Muhtar". 82, 83 The study of Celal Muhtar in the dermatophyte arena was continued by Talad, 84 and Englaender, 85 who described the first cases of favus and onychomycosis in Turkey, respectively.
Tinea capitis is one of the most common causes of paediatric dermatophyte infections of the scalp, with a propensity for attacking the hair shafts and follicles. Tinea capitis predominantly affects preadolescent children, accounting for up to 92.5% of all cases of dermatophytosis in children younger than 10 years. 86 In addition, the prevalence of asymptomatic scalp carriage (ASC) generally correlates well with the incidence of symptomatic infections regionally.
Data from Çukurova region in Turkey revealed that the prevalence of ASC is 0.1% in preliminary school children.
Notably, tinea pedis, commonly known as Athlete's foot, is particularly common in the developed world, whereas tinea capitis is relatively more prevalent in developing countries. Tinea pedis, a dermatophytic infection of the feet, can involve the interdigital web spaces or the sides of the feet and may be a chronic or recurring condition. Tinea pedis and onychomycosis seems to be a major problem among the adult Muslim male population (50 years and older) in Turkey, with a prevalence rate of 29.5%. 87 The exposure of these specific populations to sweating, trauma, occlusive footwear and communal areas predisposes these groups to that M. globosa was the most common agent, followed by M. sympodialis, M. restricta and M. furfur. 90 
| CON CLUS ION
Overall, our study reports a first picture of the frequency and epidemiological estimation of serious and invasive fungal infections in Turkey. As a limitation, the modelling estimates reported in the current study are substantially more than the documented cases, suggesting a "diagnostic gap" for fungal infections. While Turkey has a good network of professional mycologists in diagnostic laboratories and there are many publications originating from the country, the public health aspects of fungal disease are lacking.
Nonculture-based diagnostic testing is somewhat patchy in Turkey. 
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